Skip to main content
Top
Published in: Metabolic Brain Disease 6/2015

01-12-2015 | Original Article

Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease

Authors: Yi Guo, Liu Liming, Li Jiang

Published in: Metabolic Brain Disease | Issue 6/2015

Login to get access

Abstract

Intermittent maple syrup urine disease (MSUD) is a potentially life-threatening metabolic disorder caused by a deficiency of branched chain α-ketoacid dehydrogenase (BCKD) complex. In contrast to classic MSUD, children with the intermittent form usually have an atypical clinical manifestation. Here, we describe the presenting symptoms and clinical course of a Chinese boy with intermittent MSUD. Mutation analysis identified two previously unreported mutations in exon 7 of the BCKDHB gene: c.767A > G (p.Y256C) and c.768C > G (p.Y256X); the parents were each heterozygous for one of these mutations. In silico analysis predicted Y256C probably affects protein structure; Y256X leads to a premature stop codon. This case demonstrates intermittent MSUD should be suspected in cases with symptoms of recurrent encephalopathy, especially ataxia or marked drowsiness, which usually present after the neonatal period and in conjunction with infection. symmetrical basal ganglia damage but normal myelination in the posterior limb will assist differential diagnosis; alloisoleucine is a useful diagnostic marker and mutation analysis may be of prognostic value. These novel mutations Y256C and Y256X result in the clinical manifestation of a variant form of MSUD, expanding the mutation spectrum of this disease.
Literature
go back to reference Axler O, Holmquist P (2014) Intermittent maple syrup urine disease: two case reports. Pediatrics 133(2):e458–60CrossRefPubMed Axler O, Holmquist P (2014) Intermittent maple syrup urine disease: two case reports. Pediatrics 133(2):e458–60CrossRefPubMed
go back to reference Bindu PS, Shehanaz KE, Christopher R, Pal PK, Ravishankar S (2007) Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India. J Child Neurol 22(7):911–3CrossRefPubMed Bindu PS, Shehanaz KE, Christopher R, Pal PK, Ravishankar S (2007) Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India. J Child Neurol 22(7):911–3CrossRefPubMed
go back to reference Bindu PS, Kovoor JM, Christopher R (2010) Teaching NeuroImages: MRI in maple syrup urine disease. Neurology 74(3):516–524CrossRef Bindu PS, Kovoor JM, Christopher R (2010) Teaching NeuroImages: MRI in maple syrup urine disease. Neurology 74(3):516–524CrossRef
go back to reference Hou JW, Hwang TL (2014) Different gene preferences of maple syrup urine disease in the aboriginal tribes of Taiwan. Pediatr Neonatol 55(3):213–7CrossRefPubMed Hou JW, Hwang TL (2014) Different gene preferences of maple syrup urine disease in the aboriginal tribes of Taiwan. Pediatr Neonatol 55(3):213–7CrossRefPubMed
go back to reference Jaafar N, Moleirinho A, Kerkeni E et al (2013) Molecular characterization of maple syrup urine disease patients from Tunisia. Gene 517(1):116–119CrossRefPubMed Jaafar N, Moleirinho A, Kerkeni E et al (2013) Molecular characterization of maple syrup urine disease patients from Tunisia. Gene 517(1):116–119CrossRefPubMed
go back to reference Kilicarslan R, Alkan A, Demirkol D et al (2012) Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis. Jpn J Radiol 30(6):522–525CrossRefPubMed Kilicarslan R, Alkan A, Demirkol D et al (2012) Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis. Jpn J Radiol 30(6):522–525CrossRefPubMed
go back to reference Schadewaldt P, Bodner-Leidecker A, Hammen HW et al (1999) Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem 45(10):1734–1740PubMed Schadewaldt P, Bodner-Leidecker A, Hammen HW et al (1999) Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem 45(10):1734–1740PubMed
go back to reference Strauss KA, Morton DH (2003) Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr Treat Options Neurol 5:329–341CrossRefPubMed Strauss KA, Morton DH (2003) Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr Treat Options Neurol 5:329–341CrossRefPubMed
go back to reference Strauss KA, Puffenberger EG, Morton DH (1993) Maple syrup urine disease. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds) eneReviews™. University of Washington, Seattle Strauss KA, Puffenberger EG, Morton DH (1993) Maple syrup urine disease. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds) eneReviews™. University of Washington, Seattle
go back to reference Wang YP, Qi ML, Li TT, Zhao YJ (2012) Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD). Gene 498(1):112–5CrossRefPubMed Wang YP, Qi ML, Li TT, Zhao YJ (2012) Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD). Gene 498(1):112–5CrossRefPubMed
go back to reference Wynn RM, Machius M, Chuang JL, Li J, Tomchick DR, Chuang DT (2003) Roles of His291-αand His146-βin the reductive acylation reaction catalyzed by human ranched-chain α-ketoacid dehydrogenase: refined phosphorylation loop structure in the active site. J Biol Chem 278:43402–43410CrossRefPubMed Wynn RM, Machius M, Chuang JL, Li J, Tomchick DR, Chuang DT (2003) Roles of His291-αand His146-βin the reductive acylation reaction catalyzed by human ranched-chain α-ketoacid dehydrogenase: refined phosphorylation loop structure in the active site. J Biol Chem 278:43402–43410CrossRefPubMed
go back to reference Yang N, Han L, Gu X et al (2012) Analysis of gene mutations in Chinese patients with maple syrup urine disease. Mol Genet Metab 106(4):412–418CrossRefPubMed Yang N, Han L, Gu X et al (2012) Analysis of gene mutations in Chinese patients with maple syrup urine disease. Mol Genet Metab 106(4):412–418CrossRefPubMed
go back to reference Zhao Y, Hawes J, Popov KM, Jaskiewicz J, Shimomura Y, Crabb DW, Harris RA (1994) Site-directed mutagenesis of phosphorylation sites of the branched chainα-ketoacid ehydrogenase complex. J Biol Chem 269:18583–18587PubMed Zhao Y, Hawes J, Popov KM, Jaskiewicz J, Shimomura Y, Crabb DW, Harris RA (1994) Site-directed mutagenesis of phosphorylation sites of the branched chainα-ketoacid ehydrogenase complex. J Biol Chem 269:18583–18587PubMed
go back to reference Zinnanti WJ, Lazovic J, Griffin K et al (2009) Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132(4):903–918PubMedCentralCrossRefPubMed Zinnanti WJ, Lazovic J, Griffin K et al (2009) Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132(4):903–918PubMedCentralCrossRefPubMed
Metadata
Title
Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease
Authors
Yi Guo
Liu Liming
Li Jiang
Publication date
01-12-2015
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 6/2015
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-015-9711-z

Other articles of this Issue 6/2015

Metabolic Brain Disease 6/2015 Go to the issue